Cannabis legalization spurs innovation, but not always in ways that benefit patients or public health
Innovation in health care saves lives. But not all health innovations have enough evidence to actually benefit patients. Barriers to innovation are often higher in illicit or restricted markets, including cannabis, stem cells and cryptocurrencies. Researchers face higher costs, limited access to raw materials and data, and stricter regulations. Cannabis illustrates a particularly confusing tension […]
Continue Reading
